ci 934 has been researched along with gatifloxacin in 1 studies
Studies (ci 934) | Trials (ci 934) | Recent Studies (post-2010) (ci 934) | Studies (gatifloxacin) | Trials (gatifloxacin) | Recent Studies (post-2010) (gatifloxacin) |
---|---|---|---|---|---|
33 | 0 | 2 | 1,047 | 131 | 268 |
Protein | Taxonomy | ci 934 (IC50) | gatifloxacin (IC50) |
---|---|---|---|
DNA gyrase subunit A | Escherichia coli K-12 | 0.5 | |
DNA gyrase subunit B | Escherichia coli K-12 | 0.5 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 1.2 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 9.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-March, FJ; Jaén-Oltra, J; Pérez-Giménez, F; Salabert-Salvador, MT; Tomás-Vert, F | 1 |
1 other study(ies) available for ci 934 and gatifloxacin
Article | Year |
---|---|
Artificial neural network applied to prediction of fluorquinolone antibacterial activity by topological methods.
Topics: Algorithms; Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Neural Networks, Computer; Structure-Activity Relationship | 2000 |